Alerts will be sent to your verified email
Verify Email
CBPL
|
Chandra Bhagat Pharm
|
Guj. Terce Lab
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.7 % | -8.22 % | 11.51 % |
|
5yr average Equity Multiplier
|
2.82 | 3.01 | 3.24 |
|
5yr Average Asset Turnover Ratio
|
1.54 | 1.65 | 0.88 |
|
5yr Avg Net Profit Margin
|
0.58 % | -2.03 % | 1.44 % |
|
Price to Book
|
0.0 | 6.18 | 0.61 |
|
P/E
|
49.3 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
56.06 Days | -31.87 Days | 57.8 Days |
|
Inventory Days
|
127.31 Days | 41.53 Days | 76.41 Days |
|
Days Receivable
|
39.27 Days | 51.92 Days | 195.39 Days |
|
Days Payable
|
45.24 Days | 99.88 Days | 179.71 Days |
|
5yr Average Interest Coverage Ratio
|
1.54 | -0.27 | 2.65 |
|
5yr Avg ROCE
|
10.71 % | -3.24 % | 22.81 % |
|
5yr Avg Operating Profit Margin
|
2.17 % | -1.67 % | 10.92 % |
|
5 yr average Debt to Equity
|
0.85 | 0.65 | 0.87 |
|
5yr CAGR Net Profit
|
37.62 % | -3.04 % | n/a |
|
5yr Average Return on Assets
|
0.95 % | -2.45 % | 3.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.2 % | 37.03 % | 70.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.88 % |
|
Change in Promoter Holding (3 Yrs)
|
0.78 % | 0.81 % | -0.54 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chandra Bhagat Pharm
|
Guj. Terce Lab
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|